Resmed India Profile
Key Indicators
- Authorised Capital ₹ 4.80 Cr
- Paid Up Capital ₹ 4.49 Cr
- Company Age 18 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.75 Cr
- Revenue Growth -33.39%
- Profit Growth -81.57%
- Ebitda -73.84%
- Net Worth 5.83%
- Total Assets 2.43%
About Resmed India
Resmed India Private Limited (RIPL) is a leading Private Limited Foreign Company Incorporated In India incorporated in India on 05 January 2007 and has a history of 18 years and one month. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.80 Cr and a paid-up capital of Rs 4.49 Cr.
The company currently has active open charges totaling ₹9.75 Cr.
Ashish Matta, Michael Rider, and Sandeep Gulati serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85110DL2007FTC157447
-
Company No.
157447
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
05 Jan 2007
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Resmed India Private Limited offer?
Resmed India Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, CPAP, BiPAP Machine & Accessories, VFD, PLC, HMI & Control Equipments, Industrial Control Systems, Ventilator Parts & Consumables, Respiratory Equipment Rental, Home Appliances & Kitchen Appliances, Air Purifier, CPAP Mask, Elderly Care.
Who are the key members and board of directors at Resmed India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Matta
|
Director | 26-Jul-2017 | Current |
Michael Rider
|
Director | 28-Jul-2023 | Current |
|
Sandeep Gulati
|
Director | 27-Apr-2024 | Current |
Financial Performance of Resmed India.
Resmed India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.39% decrease. The company also saw a substantial fall in profitability, with a 81.57% decrease in profit. The company's net worth moved up by a moderate rise of 5.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Resmed India?
In 2023, Resmed India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Somnoware Healthcare Systems Private LimitedAshish Matta and Michael Rider are mutual person
Charges (Loans)
₹9.75 Cr
₹0
Charges Breakdown by Lending Institutions
- The Hongkong And Shanghai Banking Corporation Limited : 9.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 May 2021 | The Hongkong And Shanghai Banking Corporation Limited | ₹9.75 Cr | Open |
How Many Employees Work at Resmed India?
Unlock and access historical data on people associated with Resmed India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Resmed India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Resmed India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
